{
}
Haun Ventures is raising $1 billion for two new funds, with $500 million earmarked for early-stage investments and $500 million for late-stage ventures, expected to close by June 2025. Founded by former federal prosecutor Katie Haun, the firm previously raised $1.5 billion in 2022 and has invested in key crypto infrastructure projects. Despite market challenges, the new fundraising is anticipated to be oversubscribed, reflecting the firm's adaptability and strategic hiring.
UBS has raised its price target on BridgeBio Pharma to $65 from $62 while maintaining a Buy rating. The biopharmaceutical company focuses on developing transformative medicines for genetic diseases and cancers, with a diverse pipeline that includes treatments for conditions like amyloidosis and achondroplasia.
BridgeBio Pharma Inc. has received US approval for its heart drug, Attruby, designed to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a serious heart condition. This positions the company to compete directly with Pfizer in a growing market. The drug will be priced at $18,759 for a 28-day supply.
BridgeBio Pharma reported a Q3 loss of $0.86 per share, outperforming the Zacks Consensus Estimate of a $1.03 loss, but revenues of $2.73 million fell short by 54.21%. The company has seen a 35.3% decline in shares this year, with a mixed earnings outlook leading to a Zacks Rank #3 (Hold). Current consensus estimates for the next quarter are -$0.99 EPS on $14.44 million in revenues.
David Baker, Demis Hassabis, and John Jumper have won the Nobel Prize in Chemistry for their groundbreaking work in computational protein design and structure prediction, significantly advancing drug design capabilities. Alnylam Pharmaceuticals seeks FDA approval for vutrisiran to treat a severe form of transthyretin amyloidosis, while Johnson & Johnson halts a bladder cancer trial for TAR-200. AstraZeneca invests in a preclinical cholesterol-lowering drug, and Astellas acquires rights to an experimental gene therapy for frontotemporal dementia.
BridgeBio Pharma, Inc.
Companies
| Symbol | BBIO |
| Name | BridgeBio Pharma, Inc. |
| Currency | USD |
| Sector | Health Care |
| IndustryGroup | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Market | NASDAQ Global Select |
| Country | United States |
| State | CA |
| City | Palo Alto |
| Zipcode | 94301 |
| Website | http://www.bridgebio.com |
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
haun ventures raises one billion dollars for new crypto investment funds
03:00 23.03.2025
ubs raises bridgebio pharma price target to sixty five dollars maintains buy rating
13:17 19.03.2025
bridgebio receives us approval for heart drug to rival pfizer
01:34 23.11.2024
bridgebio pharma reports q3 loss and misses revenue estimates
14:45 12.11.2024
nobel prize awarded for protein design and drug developments advance
United States Dollar
Eli Lilly and Company
AviadoBio
Alnylam Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Amgen Inc.
Astellas Pharma Inc.
Pfizer Inc.
BridgeBio Pharma, Inc.
Novartis AG
AstraZeneca PLC
Johnson & Johnson
USA
SWE
JPN
BRA
HKG
John Jumper
David Baker
Jonathan Gardner
Demis Hassabis
Jim Wilson
Show more
13:00 09.10.2024
Trending
Subcategory
Startups & Entrepreneurship
Industry Trends
Corporate News
Private Equity Deals
Retail and Consumer Goods
Supply Chain Management
Global Trade Developments
CEO Changes
Government Economic Policies
Corporate Social Responsibility
Industry Mergers & Acquisitions
Workplace Trends
Energy Sector Developments
Venture Capital Investments
Fintech Startups
Finance Mergers & Acquisitions
AI Innovations
Market Analysis and Predictions
Intellectual Property Laws
Central Bank Actions
Countries:
Companies:
Apple Inc.
NVIDIA Corporation
Google Inc.
Amazon.com, Inc.
Tesla, Inc.
Salesforce, Inc.
Garuda Aerospace Ltd.
Huawei Technologies CO. Ltd.
Bharti Airtel Ltd.
XPeng Inc.
Microsoft Corporation
Venturewave Capital NO.1 Ltd.
Semler Scientific, Inc.
TENCENT
Wipro Ltd
OpenAI ERC USD
Orange S.A.
IDBI Bank Limited
Standard Chartered Bank
LENOVO GROUP
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Saudi Riyal
Japanese Yen
Malaysian Ringgit
British Pound Sterling
Mexican Peso
Brazilian Real
New Taiwan Dollar
Bahraini Dinar
Qatari Riyal
Pakistani Rupee
Kuwaiti Dinar
Vietnamese Đồng
South Korean Won
Algerian Dinar
People:
Donald Trump
Mark Zuckerberg
Bisrat Degefa
He Xiaopeng
Abdel Fattah El-Sisi
Anmol Singh Jaggi
Puneet Singh Jaggi
Sari Sabban
David Watkins
Simon Moon
Anas Algahtani
Matt Jones
Ayman Hamdan
Elon Musk
Allen Law
Xi Jinping
Anwar Hussain
Sultan Ibrahim ibni Sultan Iskandar
Prashant Joshi
Albinder Dhindsa